Skip to main content
Equibles

AQR CAPITAL MANAGEMENT LLC

Position in VYGR — Voyager Therapeutics, Inc.

CIK 1167557 Greenwich, CT
Back to VYGR Full portfolio

Position in VYGR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,246,380
+$348,234 QoQ
Shares Held
356,109
+53.0% QoQ
Ownership
0.578%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 135 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VYGR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

AQR CAPITAL MANAGEMENT LLC holds $5,658,888,286 across 216 Biotechnology names. VYGR ranks #144 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 1,126,080 $702,155,918
2 INCY
Incyte Corp
 5,320,901 $603,177,333
3 EXEL
Exelixis, Inc.
 11,023,943 $599,812,735
4 JAZZ
Jazz Pharmaceuticals plc
 1,522,568 $366,893,205
5 BMRN
Biomarin Pharmaceutical Inc
 5,699,541 $326,127,732
6 VRTX
Vertex Pharmaceuticals Inc / Ma
 616,170 $306,070,117
7 RVMD
Revolution Medicines, Inc.
 1,295,450 $242,611,869
8 RPRX
Royalty Pharma plc
 4,305,412 $241,404,446

All Filings in VYGR

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,246,380 356,109
2026-03-31 $898,146 232,681
2025-12-31 $628,942 160,037
2025-09-30 $822,927 176,216
2025-06-30 $880,769 283,206
2025-03-31 $1,673,976 495,260
2024-12-31 $1,005,477 177,333
2024-09-30 $1,454,444 248,623
2024-06-30 $3,973,785 502,375
2024-03-31 $7,388,731 793,634
2023-12-31 $5,395,582 639,287
2023-09-30 $1,540,870 198,822
2021-06-30 $686,942 166,330
2021-03-31 $1,707,082 362,438
2020-12-31 $1,196,588 167,355
2020-09-30 $276,566 25,920
2020-06-30 $650,737 51,564
2020-03-31 $535,549 58,530